Table 2
Open in new tab

Haemodynamic observation and interventions

Overall n = 237Cardiac arrest centre n = 165 (70%)Not cardiac arrest centre n = 72 (30%)P-value
Diagnostic possibilities
ȃAccess to echocardiography 24/7204 (87%)158 (96%)46 (65%)<0.001
ȃAccess to coronary angiography 24/7165 (71%)154 (94%)11 (15%)<0.001
Methods used method for cardiac output monitoring
ȃDoppler echocardiography136 (57%)104 (63%)32 (44%)0.008
ȃPICCO136 (57%)104 (63%)32 (44%)0.007
ȃPulmonary artery catheter59 (24%)56 (34%)3 (4%)<0.001
ȃNever measured26 (11%)12 (7%)14 (19%)0.006
First-line vasopressor:
ȃNoradrenaline195 (83%)140 (85%)55 (79%)0.17
ȃAdrenaline32 (14%)19 (12%)13 (19%)0.16
ȃDopamine4 (2%)3 (2%)1 (1%)0.81
ȃother5 (2%)3 (2%)2 (2%)0.75
First-line inotropic drug if indicated:
ȃDobutamine148 (64%)109 (67%)39 (56%)0.24
ȃAdrenaline40 (17%)23 (14%)17 (24%)0.14
ȃMilrinone14 (6%)12 (7%)2 (3%)0.28
ȃDopamine13 (6%)10 (6%)3 (4%)0.19
ȃLevosimendan11 (5%)5 (3%)6 (9%)0.34
ȃOther7 (3%)4 (2%)3 (4%)0.87
Lower acceptable level of mean arterial pressure
ȃ > 55 mmHg7 (3%)5 (3%)2 (3%)
ȃ > 60 mmHg39 (17%)29 (18%)10 (14%)
ȃ > 65 mmHg121 (52%)84 (52%)37 (53%)
ȃ > 70 mmHg31 (14%)18 (11%)13 (19%)
ȃ > 75 mmHg10 (4%)8 (5%)2 (3%)
ȃNo level for blood pressure24 (10%)18 (11%)6 (9%)
Type of mechanical circulatory support device when indicated
ȃIABP136 (57%)122 (74%)14 (19%)<0.001
ȃECMO105 (44%)99 (60%)6 (8%)<0.001
ȃImpella76 (32%)74 (45%)2 (3%)<0.001
ȃNot possible71 (30%)19 (12%)52 (72%)<0.001
Overall n = 237Cardiac arrest centre n = 165 (70%)Not cardiac arrest centre n = 72 (30%)P-value
Diagnostic possibilities
ȃAccess to echocardiography 24/7204 (87%)158 (96%)46 (65%)<0.001
ȃAccess to coronary angiography 24/7165 (71%)154 (94%)11 (15%)<0.001
Methods used method for cardiac output monitoring
ȃDoppler echocardiography136 (57%)104 (63%)32 (44%)0.008
ȃPICCO136 (57%)104 (63%)32 (44%)0.007
ȃPulmonary artery catheter59 (24%)56 (34%)3 (4%)<0.001
ȃNever measured26 (11%)12 (7%)14 (19%)0.006
First-line vasopressor:
ȃNoradrenaline195 (83%)140 (85%)55 (79%)0.17
ȃAdrenaline32 (14%)19 (12%)13 (19%)0.16
ȃDopamine4 (2%)3 (2%)1 (1%)0.81
ȃother5 (2%)3 (2%)2 (2%)0.75
First-line inotropic drug if indicated:
ȃDobutamine148 (64%)109 (67%)39 (56%)0.24
ȃAdrenaline40 (17%)23 (14%)17 (24%)0.14
ȃMilrinone14 (6%)12 (7%)2 (3%)0.28
ȃDopamine13 (6%)10 (6%)3 (4%)0.19
ȃLevosimendan11 (5%)5 (3%)6 (9%)0.34
ȃOther7 (3%)4 (2%)3 (4%)0.87
Lower acceptable level of mean arterial pressure
ȃ > 55 mmHg7 (3%)5 (3%)2 (3%)
ȃ > 60 mmHg39 (17%)29 (18%)10 (14%)
ȃ > 65 mmHg121 (52%)84 (52%)37 (53%)
ȃ > 70 mmHg31 (14%)18 (11%)13 (19%)
ȃ > 75 mmHg10 (4%)8 (5%)2 (3%)
ȃNo level for blood pressure24 (10%)18 (11%)6 (9%)
Type of mechanical circulatory support device when indicated
ȃIABP136 (57%)122 (74%)14 (19%)<0.001
ȃECMO105 (44%)99 (60%)6 (8%)<0.001
ȃImpella76 (32%)74 (45%)2 (3%)<0.001
ȃNot possible71 (30%)19 (12%)52 (72%)<0.001
Table 2
Open in new tab

Haemodynamic observation and interventions

Overall n = 237Cardiac arrest centre n = 165 (70%)Not cardiac arrest centre n = 72 (30%)P-value
Diagnostic possibilities
ȃAccess to echocardiography 24/7204 (87%)158 (96%)46 (65%)<0.001
ȃAccess to coronary angiography 24/7165 (71%)154 (94%)11 (15%)<0.001
Methods used method for cardiac output monitoring
ȃDoppler echocardiography136 (57%)104 (63%)32 (44%)0.008
ȃPICCO136 (57%)104 (63%)32 (44%)0.007
ȃPulmonary artery catheter59 (24%)56 (34%)3 (4%)<0.001
ȃNever measured26 (11%)12 (7%)14 (19%)0.006
First-line vasopressor:
ȃNoradrenaline195 (83%)140 (85%)55 (79%)0.17
ȃAdrenaline32 (14%)19 (12%)13 (19%)0.16
ȃDopamine4 (2%)3 (2%)1 (1%)0.81
ȃother5 (2%)3 (2%)2 (2%)0.75
First-line inotropic drug if indicated:
ȃDobutamine148 (64%)109 (67%)39 (56%)0.24
ȃAdrenaline40 (17%)23 (14%)17 (24%)0.14
ȃMilrinone14 (6%)12 (7%)2 (3%)0.28
ȃDopamine13 (6%)10 (6%)3 (4%)0.19
ȃLevosimendan11 (5%)5 (3%)6 (9%)0.34
ȃOther7 (3%)4 (2%)3 (4%)0.87
Lower acceptable level of mean arterial pressure
ȃ > 55 mmHg7 (3%)5 (3%)2 (3%)
ȃ > 60 mmHg39 (17%)29 (18%)10 (14%)
ȃ > 65 mmHg121 (52%)84 (52%)37 (53%)
ȃ > 70 mmHg31 (14%)18 (11%)13 (19%)
ȃ > 75 mmHg10 (4%)8 (5%)2 (3%)
ȃNo level for blood pressure24 (10%)18 (11%)6 (9%)
Type of mechanical circulatory support device when indicated
ȃIABP136 (57%)122 (74%)14 (19%)<0.001
ȃECMO105 (44%)99 (60%)6 (8%)<0.001
ȃImpella76 (32%)74 (45%)2 (3%)<0.001
ȃNot possible71 (30%)19 (12%)52 (72%)<0.001
Overall n = 237Cardiac arrest centre n = 165 (70%)Not cardiac arrest centre n = 72 (30%)P-value
Diagnostic possibilities
ȃAccess to echocardiography 24/7204 (87%)158 (96%)46 (65%)<0.001
ȃAccess to coronary angiography 24/7165 (71%)154 (94%)11 (15%)<0.001
Methods used method for cardiac output monitoring
ȃDoppler echocardiography136 (57%)104 (63%)32 (44%)0.008
ȃPICCO136 (57%)104 (63%)32 (44%)0.007
ȃPulmonary artery catheter59 (24%)56 (34%)3 (4%)<0.001
ȃNever measured26 (11%)12 (7%)14 (19%)0.006
First-line vasopressor:
ȃNoradrenaline195 (83%)140 (85%)55 (79%)0.17
ȃAdrenaline32 (14%)19 (12%)13 (19%)0.16
ȃDopamine4 (2%)3 (2%)1 (1%)0.81
ȃother5 (2%)3 (2%)2 (2%)0.75
First-line inotropic drug if indicated:
ȃDobutamine148 (64%)109 (67%)39 (56%)0.24
ȃAdrenaline40 (17%)23 (14%)17 (24%)0.14
ȃMilrinone14 (6%)12 (7%)2 (3%)0.28
ȃDopamine13 (6%)10 (6%)3 (4%)0.19
ȃLevosimendan11 (5%)5 (3%)6 (9%)0.34
ȃOther7 (3%)4 (2%)3 (4%)0.87
Lower acceptable level of mean arterial pressure
ȃ > 55 mmHg7 (3%)5 (3%)2 (3%)
ȃ > 60 mmHg39 (17%)29 (18%)10 (14%)
ȃ > 65 mmHg121 (52%)84 (52%)37 (53%)
ȃ > 70 mmHg31 (14%)18 (11%)13 (19%)
ȃ > 75 mmHg10 (4%)8 (5%)2 (3%)
ȃNo level for blood pressure24 (10%)18 (11%)6 (9%)
Type of mechanical circulatory support device when indicated
ȃIABP136 (57%)122 (74%)14 (19%)<0.001
ȃECMO105 (44%)99 (60%)6 (8%)<0.001
ȃImpella76 (32%)74 (45%)2 (3%)<0.001
ȃNot possible71 (30%)19 (12%)52 (72%)<0.001
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close